Search Results - "Amneus, M"

Abnormal mismatch repair and other clinicopathologic predictors of poor response to progestin treatment in young women with endometrial complex atypical hyperplasia and well‐differentiated endometrial adenocarcinoma: a consecutive case series by Zakhour, M, Cohen, JG, Gibson, A, Walts, AE, Karimian, B, Baltayan, A, Aoyama, C, Garcia, L, Dhaliwal, SK, Elashoff, D, Amneus, M, Walsh, C

“…Objective To report the response to progestin therapy in young women with endometrial complex atypical hyperplasia (CAH) or FIGO grade 1 endometrial…”
Get full text

The cost-effectiveness of cancer care navigation in patients with locoregional cervical cancer undergoing primary chemoradiation by Dessources, K, Pineda, E, Amneus, M, Holschneider, C.H

Get full text

Abstract 9: Low utility of cytology screening for other lower genital tract neoplasia (LGTN) following chemoradiation (CRT) for cervical cancer (CxCA) by Park, S, Holschneider, C, Amneus, M

Get full text

A novel serum alpha fetoprotein cut-point for distinguishing malignant vs benign ovarian teratoma by Castaneda, A.V, Walker, A, Cortessis, V, Mostofizadeh, S, Cohen, J, Matsuo, K, Amneus, M, Holschneider, C.H

Get full text

Even high risk women lack knowledge of obesity's impact on risk for endometrial cancer by Beavis, A, Cheema, S, Holschneider, C, Duffy, E, Amneus, M

Get full text

Cervical cancer navigation: A means to improve timely completion of primary chemoradiation by Pineda, E, Holschneider, C.H, Amneus, M

Get full text

Routine bilateral salpingectomy at the time of hysterectomy with ovarian preservation by Park, S, Amneus, M, Holschneider, C

Get full text

Reintegration of cervical cancer survivors: A survey of women’s health providers by Viveros, L, Kagawa-Singer, M, Holschneider, C, Amneus, M

Get full text

Evaluation of a post-treatment surveillance strategy after primary chemoradiation for cervical cancer by Park, S, Holschneider, C, Amneus, M

Get full text

Significance of atrophy on endometrial sampling in women 50 years of age or younger by Brunette, L, Katzir, L, Amneus, M, Aoyama, C, Holschneider, C

Get full text

Quality of life following panniculectomy for gynecologic cancer surgery by Picazo, R, Diaz, E, Fleming, N, Amneus, M, Lentz, S

Get full text

The delivery of "optimal" chemoradiation for cervical cancer at a county hospital by Amneus, M, Park, S, Holschneider, C

Get full text

Identification of Biomarkers for Ovarian Cancer Using Strong Anion-Exchange ProteinChips: Potential Use in Diagnosis and Prognosis by Kozak, Katherine R., Amneus, Malaika W., Pusey, Suzanne M., Su, Feng, Luong, Mui N., Luong, Sam A., Reddy, Srinivasa T., Farias-Eisner, Robin

“…One hundred eighty-four serum samples from patients with ovarian cancer (n = 109), patients with benign tumors (n = 19), and healthy donors (n = 56) were…”
Get full text

Before and after GOG 99: Did our practice patterns for treatment of intermediate risk endometrial adenocarcinoma change? by Ioffe, Y, Delic, L, Amneus, M, Leuchter, R, Karlan, B, Li, A, Walsh, C, Lentz, S, Farias-Eisner, R, Cass, I

Get full text

An analysis of factors contributing to patients failing to receive brachytherapy as part of primary chemoradiation for locoregional cervical cancer by Hari, A., Holschneider, C.H., Sinno, A.K., Amneus, M., Pineda, E.

Get full text

Significance of atrophy on endometrial sampling in women 50years of age or younger by Brunette, L., Katzir, L., Amneus, M., Aoyama, C., Holschneider, C.

Get full text

169 Uterine papillary serous and clear cell carcinoma: analysis of the impact of pelvic radiation therapy in early stage disease by Kim, B., Vongtama, R., Lee, M., Amneus, M., Walsh, C., Juillard, G., Berek, J.

Get full text

The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125? by Nossov, Vladimir, MD, Amneus, Malaika, MD, Su, Feng, MD, Lang, Jennifer, MD, Janco, Jo Marie Tran, Reddy, Srinivasa T, Farias-Eisner, Robin, MD, PhD

“…Ovarian cancer is the leading cause of death from gynecologic malignancy in the United States. More than 80% of patients present with advanced disease, with 5…”
Get full text

Validation of serum biomarkers for detection of early-stage ovarian cancer by Nosov, Vladimir, MD, Su, Feng, MD, Amneus, Malaika, MD, Birrer, Michael, MD, PhD, Robins, Terry, PhD, Kotlerman, Jenny, MS, Reddy, Srinivasa, PhD, Farias-Eisner, Robin, MD, PhD

“…Objective Ovarian cancer has the highest mortality of all the gynecologic malignancies with most patients diagnosed at late stages. Serum CA-125 is elevated in…”
Get full text

Pathologic quiz case: a rare tumor of the ovary by Amneus, Malaika W, Natarajan, Sathima

Get full text